ARCHIVES

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009

Litton Awarded $342,618 For Frederick Fee

February 21, 1975

Dipersio Is Chief Of Oncology At Washington University.

July 14, 2000

In Brief: Fidler Wins BMS Cancer Research Award; Thomas Cech To Head Howard Hughs Inst.

April 2, 1999

Reorganization, Money Will Cure Cancer In 21st Century, NCLAC Report Promises.

September 28, 2001

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980